Related content

Growth Inhibition of Insulin-Like Growth Factor I Receptor Monoclonal Antibody to Human Colorectal Cancer Cells

By Zhang Youcheng   Zhang Yawu  

Cancer Investigation, Vol. 26, Iss. 3, 2008-01 ,pp. : 230-236

Informa Healthcare

Access to resources Recommend Favorite

Phase I study of humanized monoclonal antibody AVE1642 directed against the type 1 insulin-like growth factor receptor (IGF-1R), administered in combination with anticancer therapies to patients with advanced solid tumors

By Macaulay V. M.   Middleton M. R.   Protheroe A. S.   Tolcher A.   Dieras V.   Sessa C.   Bahleda R.   Blay J.-Y.   LoRusso P.   Mery-Mignard D.   Soria J.-C.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 784-791

Oxford University Press

Access to resources Recommend Favorite

The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance

By Gross J.M.  

Cancer and Metastasis Reviews, Vol. 22, Iss. 4, 2003-12 ,pp. : 327-336

Springer Publishing Company

Access to resources Recommend Favorite

Type I Insulin-like Growth Factor Receptors in Human Colorectal Cancer

By Adenis A.   Peyrat J.-P.   Hecquet B.   Delobelle A.   Depadt G.   Quandalle P.   Bonneterre J.   Demaille A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 50-55

Elsevier

Access to resources Recommend Favorite

Mutational analysis of the insulinlike growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1073-1079

Science Publishers

Access to resources Recommend Favorite